ArticleJapanese journal of radiology2026
Machine learning pipeline for automated segmentation and classification of complicated cystic renal masses on MRI: comparison with radiologists' assessments.
Article in Japanese journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Percutaneous thermal ablation for renal cell carcinoma: a comprehensive review of current evidence and future directions.La Radiologia medica · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
purposeTo develop and validate a machine learning (ML)-based pipeline for automated segmentation and classification of complicated cystic renal masses (cCRMs) on MRI. MATERIALS AND
methodsThis multicenter retrospective study enrolled 275 patients (median age, 48 years; 85 females) with pathologically confirmed 275 cCRMs (203 malignant) who underwent renal MRI from January 2013 to December 2023. cCRMs from one institution were used as a training set (n = 215), while those from the other three institutions served as a test set (n = 60). 3D V-Net and random forest algorithms were employed for segmentation and classification, respectively. Segmentation and classification performance was evaluated using the Dice similarity coefficient (DSC) and the area under the curve (AUC), respectively. Two junior and two senior radiologists independently classified cCRMs in the test set into Bosniak categories II-IV based on the Bosniak classification, version 2019.
resultsIn the test set, the ML pipeline achieved DSC of 0.718 for cCRMs (n = 60) on excretory phase images. Additionally, classification performance of the ML pipeline (AUC = 0.835, 95% confidence interval [CI]: 0.717-0.919) significantly surpassed the junior radiologists (0.835 vs. 0.641, P = 0.042) and matched the senior radiologists (0.835 vs. 0.799, P = 0.684).
conclusionThe ML pipeline demonstrates expert-level diagnostic accuracy for automated segmentation and classification of cCRMs, potentially mitigating interobserver variability while maintaining robust performance across multicenter institutional data.
Indexed as
Identifiers
41269543What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.